✕
Stent ‘overpricing’: Pricing regulator to audit angioplasty cases in errant hospitals
Apr 29, 201798 viewsFaced with complaints of overcharging, and half-hearted or “inconclusive” explanations from hospitals, the National Pharmaceutical Pricing Authority has initiated audit of all angioplasty cases in several hospitals and medical institutions across the country since the notification ceiling the prices of stents was issued in February.
http://indianexpress.com/article/india/stent-overpricing-pricing-regulator-to-audit-angioplasty-cases-in-errant-hospitals-4632557/
http://indianexpress.com/article/india/stent-overpricing-pricing-regulator-to-audit-angioplasty-cases-in-errant-hospitals-4632557/
Like
Comment
Share
